Synexus, Northumbria Healthcare partner

Monday, November 18, 2013 01:53 PM

Synexus has partnered with Northumbria HealthcareNHS Foundation Trust to establish a clinical research facility at Hexham General Hospital, in North East England.

More... »

WIRB Copernicus Group

MHRA, BIA call for earlier access to medicines in the U.K.

Monday, November 18, 2013 01:39 PM

Following the publication of the report on innovation in the regulation of healthcare by the Medicines and Healthcare Products Regulatory Agency (MHRA), the BioIndustry Association (BIA) urges the U.K. government to implement a properly funded and reimbursed Earlier Access to medicines Scheme (EAS), which the group makes its number one recommendation.

More... »

CRF Health eCOA webinar series

Congressman calls for U.S. to join international trial, disease initiatives

Friday, November 15, 2013 01:06 PM

In a speech to the European Commission, U.S. Representative Chaka Fattah of Pennsylvania reiterated American support for international brain research collaboration and pledged his commitment to engaging the U.S. in two E.U.-led initiatives around clinical trials and neurodegenerative diseases.

More... »

Scientists a step closer to developing vaccine against C. difficile

Friday, November 8, 2013 12:10 PM

A group of scientists from across Europe have launched a three-year project aimed at developing an oral vaccine against Clostridium difficile, an infection that kills around 4,000 people a year (almost four-times more than MRSA) and for which there currently is no effective treatments.

More... »

Novartis proposes to close U.K. site, 371 jobs may be cut

Wednesday, November 6, 2013 12:57 PM

Novartis U.K. will initiate consultation on proposals to close its Horsham site in West Sussex, affecting up to 371 employees, but subject to an employee consultation process and final U.K. board approval.

More... »

New Pfizer INSPIRE site launched in Scotland

Wednesday, November 6, 2013 12:50 PM

Scottish patients will benefit from the latest medical advances under a new Pfizer and NHS Scotland partnership for clinical trials.

More... »

Pfizer responds to U.K. pharma pricing deal

Wednesday, November 6, 2013 12:43 PM

Pfizer released a statement calling the new Pharmaceutical Price Regulation Scheme (PPRS), agreed to by the U.K. government and industry, a missed opportunity for British patients, the U.K. economy and industry.

More... »

Roche, Polyphor partner on multi-drug-resistant bacterial infections

Monday, November 4, 2013 01:39 PM

Roche and Polyphor, a privately-held Swiss pharmaceutical company, have entered into an exclusive worldwide license agreement to develop and commercialize Polyphor’s investigational macrocycle antibiotic, POL7080, for patients suffering from bacterial infections caused by Pseudomonas aeruginosa.

More... »

Synexus opens regional center in Poland to support global clinical trials

Wednesday, October 30, 2013 09:05 AM

Synexus has opened a regional office for Eastern Europe in Poland, reflecting the company’s commitment to the region.

More... »

AB-Biotics acquires patent for predicting antipsychotic-induced extrapyramidal symptoms

Tuesday, October 29, 2013 10:00 AM

The Spanish biotech company AB-Biotics has acquired the rights to a patent which predicts the high or low risk of a patient treated with antipsychotic drugs developing extrapyramidal symptoms. Side effects induced by antipsychotic drugs affect patient movement and include muscle rigidity, parkinsonism, akinesia (inability to initiate movement) and akathisia (inability to remain motionless).

More... »

CenterWatch Data Library



Browse by:


July 28

WCG acquires Alliance Biosciences to expand its biosafety oversight capabilities, ensure compliance

Facilitated review meetings for protocol design catching on, decreasing amendments, complexity

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly


IRB market consolidating rapidly
Private equity driving a new commercial ethical review landscape

Lessons learned from medical device trials
Smaller, faster, more flexible trials hold important insights for pharmaceutical innovation

Already a subscriber?
Log in to your digital subscription.

Purchase the July issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly


CRO market poised for growth and consolidation
Sponsors expanding pipelines, shrinking infrastructure fuel strategic outsourcing

Strategies for success evolving in phase I space
Sites see increasing complexity, more patients, greater focus on efficacy

Already a subscriber?
Log in to your digital subscription.

Purchase the June issue.

Subscribe to
The CenterWatch Monthly.


Featured Jobs